Skip to content
Disclosery

ORBIMED ADVISORS LLC: KROS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on KROS, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 759,155 KROS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 759,155 shares
    Change vs previous 13F 0 shares

    0.15% of the 13F portfolio, value $8,122,959.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 759,155 shares
    Change vs previous 13F -45,057 shares

    0.18% of the 13F portfolio, value $8,381,071.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 804,212 shares
    Change vs previous 13F -214,522 shares

    0.34% of the 13F portfolio, value $16,373,756.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,018,734 shares
    Change vs previous 13F 0 shares

    0.39% of the 13F portfolio, value $16,116,372.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,018,734 shares
    Change vs previous 13F 0 shares

    0.34% of the 13F portfolio, value $13,600,099.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,018,734 shares
    Change vs previous 13F 0 shares

    0.25% of the 13F portfolio, value $10,380,899.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,018,734 shares
    Change vs previous 13F 0 shares

    0.33% of the 13F portfolio, value $16,126,559.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,018,734 shares
    Change vs previous 13F not available

    1.08% of the 13F portfolio, value $59,157,883.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).